Welcome to visit Acta Anatomica Sinica! Today is
Chinese
Gene knockout of amyloid precursor protein promotes aluminum-induced cognitive impairment in mice
WANG Dong-mei YUAN Shu-min ZHANG Xu ZHANG Lian-feng
Acta Anatomica Sinica ›› 2013, Vol. 44 ›› Issue (4) : 451-455.
Gene knockout of amyloid precursor protein promotes aluminum-induced cognitive impairment in mice
Objective Amyloid precursor protein (APP) is involved in dementia, however, little is known about its role in the development of dementia. The APP knockout mice were used to investigate the effects of amyloid precursor protein on
aluminum-induced cognitive impairment in mice. Methods APP knockout mice and the littermates of no-negative mice aged 3 months were selected randomly and performed Morris water-maze tests after administration for 8 weeks. Aluminum was administrated in the diet. One group of APP knockout mice was used for vehicle group. One group of the littermates of no-negative mice was used as normal control (WT). The pathological changes in brain were detected by HE staining. The activities of glycogen synthase kinase 3β(GSK-3β)and Caspase-3 were also examined by Western blotting. Results Compared with WT mice, Al-treated WT mice exhibited a decrease in the target-quadrant abidance by 28.1% and the crossing-target number by 18.8% in the probe test; APP knockout mice administrated showed a significant decrease in the target-quadrant abidance by 44.1% and the crossing-target number by 51% in the probe test. Compared with that of WT mice, the level of p-GSK-3β was decreased by 17.4% in Al-treated WT mice and by 46.4% in Al-treated APP knockout mice. Conclusion Gene knockout of APP promotes aluminum-induced neurotoxicity and cognitive impairment in mice. APP knockout leads to a significant increase of the activity of GSK-3β, which can accelerate the processing of dementia. Thus the protective effect of APP may be through inhibiting the activity of GSK-3β.
Amyloid ecursor protein / Aluminum / Morris water maze / Cognitive impairment / Glycogen synthase kinase 3β / Mouse
1］Stokin GB, Lillo C, Falzone TL, et al. Axonopathy and transport deficits early in the pathogenesis of Alzheimer,s disease［J］. Science, 2005, 307 (5713): 1282-1288.
［2］Savva GM, Wharton SB, Ince PG, et al. Age, neuropathology, and dementia［J］. N Engl J Med, 2009, 360 (22): 2302-2309.
［3］Iqbal K,Grundke-Iqbal I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and
prevention［J］. J Cell Mol Med, 2008, 12 (1): 38-55.
［4］Holmes C, Boche D, Wilkinson D, et al. Long-term effects of Abeta42 immunisation in Alzheimer.s disease: follow-up of a
randomised, placebo-controlled phase I trial［J］. Lancet, 2008, 372 (9634): 216-223.
［5］Mattson MP. Pathways towards and away from Alzheimer,s disease［J］. Nature, 2004, 430 (7000): 631-639.
［6］Golub MS,Keen CL. Effects of dietary aluminum on pubertal mice［J］. Neurotoxicol Teratol, 1999, 21 (5): 595-602.
［7］Ribes D, Colomina MT, Vicens P, et al. Effects of oral aluminum exposure on behavior and neurogenesis in a transgenic
mouse model of Alzheimer,s disease［J］. Exp Neurol, 2008, 214 (2): 293-300.
［8］Laczo J, Vlcek K, Vyhnalek M, et al. Spatial navigation testing discriminates two types of amnestic mild cognitive
impairment［J］. Behav Brain Res, 2009, 202 (2): 252-259.
［9］Reinhard C, Hebert SS,De Strooper B. The amyloid-beta precursor protein: integrating structure with biological function
［J］. EMBO J, 2005, 24 (23): 3996-4006.
［10］Dawson GR, Seabrook GR, Zheng H, et al. Age-related cognitive deficits, impaired long-term potentiation and reduction
in synaptic marker density in mice lacking the beta-amyloid precursor protein［J］. Neuroscience, 1999, 90 (1): 1-13.
［11］Frisardi V, Solfrizzi V, Capurso C, et al. Aluminum in the diet and Alzheimer,s disease: from current epidemiology to
possible disease-modifying treatment［J］. J Alzheimers Dis, 2010, 20 (1): 17-30.
［12］Lin R, Chen X, Li W, et al. Exposure to metal ions regulates mRNA levels of APP and BACE1 in PC12 cells: blockage by
curcumin［J］. Neurosci Lett, 2008, 440 (3): 344-347.
［13］Tanino H, Shimohama S, Sasaki Y, et al. Increase in phospholipase C-delta1 protein levels in aluminum-treated rat brains
［J］. Biochem Biophys Res Commun, 2000, 271 (3): 620-625.
［14］Steinbrecher KA, Wilson W, Cogswell PC, et al. Glycogen synthase kinase 3beta functions to specify gene-specific,
NF-kappaB-dependent transcription［J］. Mol Cell Biol, 2005, 25 (19): 8444-8455.
［15］Liu SJ, Zhang AH, Li HL, et al. Overactivation of glycogen synthase kinase-3 by inhibition of phosphoinositol-3 kinase
and protein kinase C leads to hyperphosphorylation of tau and impairment of spatial memory［J］. J Neurochem, 2003, 87
(6): 1333-1344.
［16］Zeng YQ, Chen XCh, Huang Ch, et al. The attenuation of β-amyloid peptide25-35 -induced tau hyperphosporylation in cortical
neurons by the regulation of ginsenoside Rg1 on the activity of GSK-3β and PP2A［J］. Acta Anatomica Sinica, 2007, 38
(6): 665-670.(in Chinese)
曾育琦, 陈晓春, 黄春, 等. 人参皂苷Rg1通过调节GSK-3β/PP2A活性减轻皮层神经元Tau蛋白过度磷酸化［J］. 解剖学报， 2007, 38
(6): 665-670.
［17］Tomljenovic L. Aluminum and Alzheimer,s disease: after a century of controversy, is there a plausible link［J］? J
Alzheimers Dis, 2011, 23 (4): 567-598.
/
| 〈 |
|
〉 |
